| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |